Finally, anti-ANXA2 mAbs significantly inhibited EGF-induced proliferation and metastasis by successfully blocking of EGFR homo-dimerization, phosphorylation and internalization in breast cancer [37]. This evidence concerns the gene EGFR and breast carcinoma.